Daxor (DXR.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Aug30

Daxor released FY2025 Q1 earnings on August 29 (EST), actual revenue USD 9.174K, actual EPS USD -0.037

03:00

Daxor released FY2025 Semi-Annual Earnings on August 29 (EST), actual revenue USD 18.35 K, actual EPS USD -0.0741

03:00

Daxor released FY2025 Q2 earnings on August 29 (EST), actual revenue USD 9.174 K, actual EPS USD -0.037

03:00

Apr10

Daxor Corporation Submits 510(K) Application for Next-Generation Blood Volume Analyzer to FDA

13:47

Apr7

DAXOR Corp CEO Feldschuh Purchases 2,063 Shares

19:32

Mar4

Daxor Corporation Reports 116.5% Year-over-Year Revenue Growth for 2024 and Strong Start in 2025

13:08

Schedules & Filings

Schedules

Filings

Aug29

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 9.174 K, Net Income -184.85 K, EPS -0.037

Mar3

Earning Release(EST)

FY2024 Q4 Earning Release (USD) Revenue 23.98 K, Net Income 1.084 M, EPS 0.2196

Aug29

Earning Release(EST)

FY2024 Q2 Earning Release (USD) Revenue 35.88 K, Net Income -815.41 K, EPS -0.1684

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More